- Lobbying
- american AND pharmacies
Lobbying Arrangements Results for 'American Pharmacies'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Pharmacy benefit manager issues pharmacist provider status issues |
American Associated Pharmacies
Trade association of independent pharmacies |
Fidelis Government Relations | |||
Details Pharmacy benefit manager regulations Pharmacy provider status issues |
American Pharmacy Cooperative, Inc.
Trade Association of independent pharmacies |
Fidelis Government Relations | |||
Details legislative and regulatory issues related to independent pharmacy and pharmacy benefit managers (PBMs). H.R. 1613/S. 1038, Drug Price Transparency in Medicaid Act H.R. 2816, PBM Sunshine and Accoun... |
American Pharmacies, Inc.
|
Roberti Global (f/k/a Roberti White, LLC) | |||
Details Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA certi... |
Walgreens Co.
|
Forbes-Tate | |||
Details Issues pertaining to Medicare reimbursement. Issues pertaining to Medicare coverage decisions. Issues pertaining to Prescription Drug Monitoring. Public Health. Monitor legislation and oversight o... |
American Society of Interventional Pain Physicians
|
Ryan MacKinnon Vasapoli and Berzok, LLP | |||
Details Prescription drug pricing generally Pharmacy Benefit Manager (PBM) reform generally S. 2973 (Modernizing and Ensuring PBM Accountability Act), all provisions S. 1339 (Pharmacy Benefit Manager Refor... |
American Pharmacy Cooperative, Inc.
|
ArentFox Schiff LLP | |||
Details Advocacy on Medicare and Medicaid pharmacy coverage and reimbursement issues. Advocating for coverage of pharmacists services under Medicare Part B. Advocating for the passage of legislation that... |
National Association of Chain Drug Stores
|
AMERICAN CONTINENTAL GROUP | |||
Details Insulin Copay Caps, Drug Pricing, Pharmacy Benefit Manager (PBM) Reform, Generic Drug Manufacturing Senate Finance Committee PBM Reform Framework H.R. 5378 - The Lower Costs, More Transparency Ac... |
HIGHMARK, INC.
|
in-house lobbying | |||
Details Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repa... |
AMERICAN SOCIETY OF ADDICTION MEDICINE
|
in-house lobbying | |||
Details Educate policymakers on pharmacy issues related to TRICARE and H.R. 2670, S.2226 Fiscal Year 2024 National Defense Authorization Act; issues related to removing barriers to biosimilar medicine acce... |
CIGNA Corporation
|
Invariant LLC | |||
Details Public Law 111-148, the Patient Protection and Affordable Care Act - Implementation issues related to Medicare and Medicaid physician payments, health insurance market reforms, delivery system refo... |
American Medical Association
|
Tarplin Strategies LLC | |||
Details Issues related to drug pricing, drug shortages, and the drug supply chain, including support for the following bills: the Protecting Patients Against PBM Abuses Act (H.R. 2880), the Transparency an... |
American Society of Health-System Pharmacists
|
in-house lobbying | |||
Details Issues related to food industry workforce, workforce shortage, registered apprenticeship programs, second chance hiring, asylum seekers/refugees NLRA policies Protecting the Right to Organize (PRO ... |
Food Marketplace Inc.
|
in-house lobbying | |||
Details H.R. 933, Consolidated and Further Continuing Appropriations Act (Rogers) - FY 2013 appropriations for HHS programs and agencies. H.R. 1326, Health Care Price Transparency Promotion Act (Burgess) ... |
Americas Health Insurance Plans (AHIP)
|
C2 GROUP, LLC | |||
Details Issues related to the Improving Seniors Timely Access to Care Act of 2021; Issues related to Pharmacy Direct and Indirect Remuneration (DIR), including the Contract Year (CY) 2023 Policy and Techni... |
The Cigna Group and subsidiaries (Formerly Cigna Corporation and subsidiaries)
|
in-house lobbying | |||
Details Issues related to healthcare reform implementation: Health Information Technology; ARRA Privacy and Security Rules; Generic Biologics; Importation of Prescription Drugs; Competitive Bidding; Home ... |
Medco Health Solutions, Inc.
|
in-house lobbying | |||
Details H.R. 3184, the "Invest to Protect Act," a bill to establish a grant program to provide assistance to local law enforcement agencies; entire bill. H.R. 2670, FY 2024 National Defense Authorization A... |
Sergeants Benevolent Association of New York City
|
LONGBOW PUBLIC POLICY GROUP, LLC | |||
Details Issues related to: - Contact lens safety, peripheral artery disease, and stroke care, specifically to provisions regarding appropriations report language - Appropriations for Labor Health and Human... |
JOHNSON & JOHNSON SERVICES, INC.
|
in-house lobbying | |||
Details Supporting the following funding levels in FY24 appropriations bills: LHHS- $500 million for the Agency for Healthcare Research and Quality, $11.6 billion for the Centers for Disease Control and Pr... |
NATIONAL MULTIPLE SCLEROSIS SOCIETY
|
in-house lobbying | |||
Details H.R. 83, Consolidated and Further Continuing Appropriations Act - ACA risk corridor program, expatriate plans, HHS appropriations. H.R. 1326, Health Care Price Transparency Promotion Act (Burgess)... |
Americas Health Insurance Plans (AHIP)
|
FTI Government Affairs | |||
Details H.R. 766, Preventive Health Savings Act, all provisions S. 114, Preventive Health Savings Act, all provisions H.R. 5525, Continuing Appropriations and Border Security Enhancement Act, 2024, all pro... |
American Medical Association
|
in-house lobbying | |||
Details Issue: Support research with non-human primates Presidents FY 2024 Budget Request S.2624 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act,... |
Association of American Medical Colleges
|
in-house lobbying | |||
Details Hill outreach to oppose site-neutral payment cuts; Hill outreach in support of the Acute Hospital Care at Home program; Hill outreach about streamlining prior authorization in Medicare Advantage pl... |
American Hospital Association
|
in-house lobbying |